Murine Denys-Drash syndrome: Evidence of podocyte de-differentiation and systemic mediation of glomerulosclerosis

Human Molecular Genetics

Volumn 12, Issue 18, 2003, Pages 2379-2394

  Patek, Charles E ^a   Fleming, Stewart ^b   Miles, Colin G ^a,d   Bellamy, Christopher O ^c   Ladomery, Michael ^a,e   Spraggon, Lee ^a   Mullins, John ^c   Hastie, Nicholas D ^a   Hooper, Martin L ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d INSTITUTE OF HUMAN GENETICS   (United Kingdom)

^e UNIVERSITY OF THE WEST OF ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ALPHA ACTININ; ANGIOTENSIN; CYTOKERATIN; DESMIN; NEPHRIN; PROTEIN ZO1; RENIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PAX2; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; VIMENTIN; WT1 PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; CELL CYCLE; CELL DIFFERENTIATION; CELL FATE; CELL MATURATION; CELL MUTANT; CELLULAR DISTRIBUTION; CLINICAL FEATURE; CONTROLLED STUDY; DENYS DRASH SYNDROME; DISEASE COURSE; GENE LOSS; GENE MUTATION; GENETIC ANALYSIS; GLOMERULOSCLEROSIS; HETEROZYGOSITY; IMMUNOCYTOCHEMISTRY; KIDNEY DISEASE; MALE PSEUDOHERMAPHRODITISM; MARKER GENE; MEDICAL ASSESSMENT; MOUSE; NEPHROBLASTOMA; NONHUMAN; PHENOTYPE; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; TUMOR SUPPRESSOR GENE;

ANIMALS; CELL DIFFERENTIATION; DENYS-DRASH SYNDROME; DNA; GENE EXPRESSION; GENES, DOMINANT; GENES, TUMOR SUPPRESSOR; GENETIC MARKERS; GLOMERULONEPHRITIS; GLUCOSE-6-PHOSPHATE ISOMERASE; HETEROZYGOTE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KIDNEY GLOMERULUS; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; MUTATION; PHOSPHOPROTEINS; RENIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; WT1 PROTEINS;

ANIMALIA; MURINAE;

EID: 0141478977     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/ddg240     Document Type: Review

References (69)

1. Scharnhorst, V., van der Eb, A.J. and Jochemsen, A.G. (2001) WT1 proteins: functions in growth and differentiation. Gene, 273, 141-161.
2. Kreidberg, J.A., Sariola, H., Loring, J.M., Maeda, M., Pelletier, J., Housman, D. and Jaenisch, R. (1993) WT1 is required for early kidney development. Cell, 74, 677-691.
3. Moore, A.W., McInnes, L., Kreidberg, J., Hastie, N.D. and Schedl, A. (1999) YAC complementation shows a requirement for Wt1 in the development of epicardium, adrenal gland and throughout nephrogenesis. Development, 126, 1845-1857.
4. Moore, A.W., Schedl, A., McInnes, L., Doyle, M., Hecksher Sorensen, J. and Hastie, N.D. (1998) YAC transgenic analysis reveals Wilms' tumour 1 gene activity in the proliferating coelomic epithelium, developing diaphragm and limb bud. Mech. Dev., 79, 169-184.
5. Hosono, S., Luo, X., Hyink, D.P., Schnapp, L.M., Wilson, P.D., Burrow, C.R., Reddy, J.C., Atweh, G.F. and Licht, J.D. (1999) WT1 expression induces features of renal epithelial differentiation in mesenchymal fibroblasts. Oncogene, 18, 417-427.
6. Davies, J.A. and Brandli, A.W. (2001) The Kidney Development Database; www.ed.ac.uk/anatomy/database/kidbase/semantk.html
7. McTaggart, S.J., Algar, E., Chow, C.W., Powell, H.R. and Jones, C.L. (2001) Clinical spectrum of Denys-Drash and Frasier syndromes. Pediatr. Nephrol., 16, 335-339.
8. Salomon, R., Gubler, M.C. and Niaudet, P. (2000) Genetics of nephrotic syndrome. Curr. Opin. Pediatr., 12, 129-134.
9. Breslow, N.E., Takashima, J.R., Ritchey, M.L., Strong, L.C. and Green, D.M. (2000) Renal failure in the Denys-Drash and Wilms' tumour-aniridia syndromes. Cancer Res., 60, 4030-4032.
10. Menke, A.L., Ijpenberg, A., Fleming, S., Ross, A., Medine, C.N., Patek, C.E., Spraggon, L., Hughes, J., Clarke, A.R. and Hastie, N.D. (2003) The WT1-heterozygous mouse; A model to study the development of glomerular sclerosis. J. Pathol., 200, 667-674.
11. Hammes, A., Guo, J., Lutsch, G., Leheste, J.R., Landrock, D., Ziegler, U., Gubler, M.C. and Schedl, A. (2001) Two splice variants of the Wilms' tumour 1 gene have distinct functions during sex determination and nephron formation. Cell, 106, 319-329.
12. Yang, Y., Zhang, S.H., Sich, M., Beziau, A., van den Heuvel, L.P.W.J. and Gubler, M.C. (2001) Glomerular extracellular matrix and growth factors in diffuse mesangial sclerosis. Pediatr. Nephrol., 16, 429-438.
13. Wapstra, F.H., Navis, G.J., Van Goor, H., van den Born, J., Berden, J.H.M., de Jong, P.E. and de Zeeuw, D. (2000) ACE inhibition preserves heparan sulphate proteoglycans in the glomerular basement membrane of rats with established adriamycin nephropathy. Exp. Nephrol., 9, 21-27.
14. Palmer, R.E., Kotsianti, A., Cadman, B., Boyd, T., Gerald, W. and Haber, D.A. (2001) WT1 regulates the expression of the major glomerular podocyte membrane protein Podocalyxin. Curr. Biol., 11, 1805-1809.
15. Natoli, T.A., Liu, J., Eremina, V., Hodgens, K., Li, C., Hamano, Y., Mundel, P., Kalluri, R., Miner, J.H., Quaggin, S.E. and Kreidberg, J.A. (2002) A mutant form of the Wilms' tumour suppressor gene WT1 observed in Denys-Drash syndrome interferes with glomerular capillary development. J. Am. Soc. Nephrol., 13, 2058-2067.
16. Eccles, M.R., He, S., Legge, M., Kumar, R., Fox, J., Zhou, C., French, M. and Tjai, R.W.S. (2002) PAX genes in development and disease: the role of PAX2 in urogenital development. Int. J. Dev. Biol., 46, 535-544.
17. Yang, Y., Jeanpierre, C., Dressler, G.R., Lacoste, M., Niaudet, P. and Gubler, M.C. (1999) WT1 and PAX-2 podocyte expression in Denys-Drash syndrome and isolated diffuse mesangial sclerosis. Am. J. Pathol., 154, 181-192.
18. Ryan, G., Steele-Perkins, V., Morris, J.F., Rauscher, F.J. and Dressler, G.R. (1995) Repression of Pax-2 by WT1 during normal kidney development. Development, 121, 867-875.
19. Dressler, G.R., Wilkinson, J.E., Rotherpieler, U.W., Patterson, L.T., Williams-Simons, L. and Westphal, H. (1993) Deregulation of Pax-2 expression in transgenic mice generates severe kidney abnormalities. Nature, 362, 65-67.
20. Patek, C.E., Little, M.H., Fleming, S., Miles, C., Charlieu, J.P., Clarke, A.R., Miyagawa, K., Christie, S., Doig, J., Harrison, D.J. et al. (1999) A zinc finger truncation of murine WT1 results in the characteristic urogenital abnormalities of Denys-Drash syndrome. Proc. Natl Acad. Sci. USA, 96, 2931-2936.
21. Ansell, J.D., Samuel, K., Whittingham, D.G., Patek, C.E., Hardy, K., Handyside, A.H. Jones, K.W. Muggleton-Harris, A.L., Taylor, A.H. and Hooper, M.L. (1991) Hypoxanthine phosphoribosyl transferase deficiency, haematopoiesis, and fertility in the mouse. Development, 112, 489-498.
22. Guo, J.K., Menke, A.L., Gubler, M.C., Clarke, A.R., Harrison, D., Hammes, A., Hastie, N.D. and Schedl, A. (2002) WT1 is a key regulator of podocyte function: reduced expression levels cause crescentic glomerulonephritis and mesangial sclerosis. Hum. Mol. Genet., 15, 651-659.
23. Whitworth, C.E., Fleming, S., Cumming, A.D., Morton, J.J., Burns, N.J.T., Williams, B.C. and Mullins, J.J. (1994) Spontaneous development of malignant phase hypertension in transgenic Ren-2 rats. Kidney Int., 46, 1528-1532.
24. Karp, S.L., Ortiz-Arduan, A., Li, S. and Neilson, E.G. (1994) Epithelial differentiation of metanephric mesenchymal cells after stimulation with hepatocyte growth factor or embryonic spinal cord. Proc. Natl Acad. Sci. USA, 91, 5286-5290.
25. Folpe, A.L., Patterson, K. and Gown, A.M. (1997) Antibodies to desmin identify the blastemal component of nephroblastoma. Mod. Pathol., 10, 895-900.
26. Wolf, G., Butzmann, U. and Wenzel, U.O. (2003) The renin-angiotensin system and progression of renal disease: from hemodynamics to cell biology. Nephron Physiol., 93, 3-13.
27. Fleming, S. (2000) Malignant hypertension - the role of the paracrine renin-angiotensin system. J. Pathol., 192, 135-139.
28. Tryggvason, K. and Wartiovaara, J. (2001) Molecular basis of glomerular permselectivity. Curr. Opin. Nephrol. Hypertens., 10, 543-549.
29. Jadressic, L., Leake, J., Gordon, I., Dillon, M.J. Grant, D.B., Pritchard, J., Risdon, R.A. and Barratt, T.M. (1990) Clinicopathologic review of twelve children with nephropathy, Wilms tumour and genital abnormalities (Drash syndrome). J. Pediatr., 117, 717-725.
30. Vicanek, C., Ferretti, E., Goodyer, C., Torban, E., Moffet, P., Pelletier, J. and Goodyer, P. (1997) Regulation of renal EGF receptor expression in normal kidney and in Denys-Drash syndrome. Kidney Int., 52, 614-619.
31. Ramani, P. and Cowell, J.K. (1996) The expression of pattern of Wilms' tumour gene (WT1) product in normal tissues and paediatric renal tumours. J. Pathol., 179, 162-168.
32. Kent, J., Coriat, A.M., Sharpe, P.T., Hastie, N.D. and van Heyningen, V. (1995) The evolution of WT1 sequence and expression pattern in vertebrates. Oncogene, 11, 1781-1792.
33. Miyagawa, K., Kent, J., Moore, A., Charlieu, J.P., Little, M.H., Williamson, K.A., Kelsey, A., Brown, K.W., Hassam, S., Briner, J. et al. (1998) Loss of WT1 function leads to ectopic myogenesis in Wilms' tumour. Nat. Genet., 18, 15-17.
34. Sharma, P.M., Bowman, M., Yu, B-F. and Sukumar, S. (1994) A rodent model for Wilms' tumors: Embryonal kidney neoplasms induced by N-nitroso-N′-methyurea. Proc. Natl Acad. Sci. USA, 91, 9931-9935.
35. Charles, A.K., Mall, S., Watson, J. and Berry, P.J. (1997) Expression of the Wilms' tumour gene WT1 in the developing human kidney and in pediatric renal tumours: an immunohistochemical study. Mol. Pathol., 50, 138-144.
36. Scharnhorst, V., Dekker, P., van der Eb, A.J. and Jochemsen, A.G. (1999) Internal translation initiation generates novel WT1 protein isoforms with distinct biological properties. J. Biol. Chem., 274, 23456-23462.
37. Yang, Y., Gubler, M.C. and Beaufils, H. (2002) Dysregulation of podocyte phenotype in idiopathic collapsing glomerulopathy and HIV-associated nephropathy. Nephron, 91, 416-423.
38. Ohtaka, A., Ootaka, T., Sato, H., Soma, J., Sato, T., Saito, T. and Ito, S. (2000) Significance of early phenotypic change of glomerular podocytes detected by Pax2 in primary focal segmental glomerulosclerosis. Am. J. Kidney Dis., 39, 475-485.
39. Barisoni, L., Bruggeman, L.A., Mundel, P., D'Agati, V. and Klotman, P.E. (2000) HIV-1 induces renal epithelial de-differentiation in a transgenic model of HIV-associated nephropathy. Kidney Int., 58, 173-181.
40. Barisoni, L., Kriz, W., Mundel, P. and D'Agati, V. (1999) The dysregulated podocyte phenotype: A novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy. Am. J. Nephrol., 10, 51-61.
41. Bariety, J., Bruneval, P., Hill, G., Irinopoulou, T., Mandet, C. and Meyrier, A. (2001) Posttransplantation replase of FSGS is characterised by glomerular epithelial cell transdifferentiation. J. Am. Soc. Nephrol., 12, 261-274.
42. Barisoni, L., Bruggeman, L.A., Sablay, L., Nagata, M., Yamase, H. and Mundel, P. (2000) Podocyte cell cycle regulation and proliferation in collapsing glomerulopathies. Kidney Int., 58, 137-143.
43. Bariety, J., Nochy, D., Mandet, C., Jacquot, C., Glotz, D. and Meyrier, A. (1998) Podocytes undergo phenotypic changes and express macrophagic-associated markers in idiopathic collapsing glomerulopathy. Kidney Int., 53, 918-925.
44. Ohtaka, A., Ootaka, T., Sato, H. and Ito, S. (2000) Phenotypic change of glomerular podocytes in primary focal segmental glomerulosclerosis: a developmental paradigm? Nephrol. Dial. Transplant., 17, 11-15.
45. Shimojo, H. (1998) Adaptation and distortion of podocytes in rat remnant kidney. Pathol. Int., 48, 368-383.
46. Hoshi, S., Shu, Y., Yoshida, F., Inagaki, T., Sonada, J., Watanabe, T., Nomoto, K.-I. and Nagata, M. (2002) Podocyte injury promotes progressive nephropathy in Zucker diabetic fatty rats. Lab. Invest., 82, 25-35.
47. Nagata, M., Horita, S., Shu, Y., Shibata, S., Hattori, M., Ito, K. and Watanabe, T (2000) Phenotypic characteristics and cyclin-dependent kinase inhibitors repression in hyperplastic epithelial pathology in idiopathic focal segmental glomerulosclerosis. Lab. Invest., 80, 869-880.
48. Haltia, A., Solin, M.-L., Holmberg, C., Reivinen, J., Miettinen, A. and Holthofer, H. (1998) Morphologic changes suggesting abnormal renal differentiation in congenital nephrotic syndrome. Pediatr. Res., 43, 410-414.
49. Stahl, P.J. and Felsen, D. (2001) Transforming growth factor-β, basement membrane, and epithelial-mesenchymal transdifferentiation. Am. J. Pathol., 159, 1187-1192.
50. Zeisberg, M., Bonner, G., Maeshima, Y., Colorado, P., Muller, G.A., Strutz, F. and Kalluri, R. (2001) Collagen composition and assembly regulates epithelial-mesenchymal transdifferentiation. Am. J. Pathol., 159, 1313-1321.
51. Ots, M., Pechter, U. and Tamm, A. (2000) Characteristics of progressive renal disease. Clin. Chim. Acta, 297, 29-41.
52. Kawachi, H., Kurihara, H., Topham, P.S., Brown, D., Shia, M.A., Orikasa, M., Shimizu, F. and Salant, D.J. (1997) Slit diaphragm-reactive nephritogenic Mab 5-1-6 alters expression of ZO-1 in rat podocytes. Am. J. Physiol., 273, F984-F993.
53. Macconi, D., Ghilardi, M., Bonassi, M.E., Mohamed, E.I., Abbate, M., Colombi, F., Remuzzi, G. and Remuzzi, A. (2000) Effect of angiotensin-converting enzyme inhibition on glomerular basement membrane permeability and distribution of zonula occludens-1 in MWF rats. J. Am. Soc. Nephrol., 11, 477-489.
54. Wolf, G. (1998) Link between angiotensin II and TGF-β in the kidney. Miner. Electrolyte Metab., 24, 174-180.
55. Bitzer, M., Sterzel, R.B. and Bottinger, E.P. (1998) Transforming growth factor-β in renal disease. Kidney Blood Press. Res., 21, 1-12.
56. Jin, D.K., Kang, S.I., Kim, S.L., Bang, E.H., Hwang, H.Z., Tadokoro, K., Yamada, M. and Kohsaka, T. (1999) Transcriptional regulation of PDGF-A and TGF-beta by +KTS WT1 deletion mutants and a mutant mimicking Denys-Drash syndrome. Renal Fail., 21, 685-694.
57. Sim, E.U.H., Smith, A., Szilagi, E., Rae, F., Ioannou, P., Lindsay, M.H. and Little, M.H. (2002) Wnt-4 regulation by the Wilms' tumour suppressor gene, WT1. Oncogene, 21, 2948-2960.
58. Sayers, R., Kalluri, R., Rodgers, K.D., Shield, C.F., Meehan, D.T. and Cosgrove, D. (1999) Role for transforming growth factor-β1 in Alport renal disease progression. Kidney Int., 56, 1662-1673.
59. Ziyadeh, F.N., Hoffman, B.B., Han, D.C., Iglesias-de la Cruz, C., Hong, S.W., Isono, M., Chen, S.M., McGowan, T.A. and Sharma, K. (2000) Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-β in db/db diabetic mice. Proc. Natl Acad. Sci. USA, 97, 8015-8020.
60. Nitschke, R., Henger, A., Ricken, S., Gloy, J., Muller, V., Greger, R. and Pavenstadt, H. (2000) Angiotensin II increases the intracellular calcium activity in podocytes of the intact glomerulus. Kidney Int., 57, 41-49.
61. Kagami, S., Border, W.A., Miller, D.E. and Noble, N.A. (1994) Angiotensin II stimulates extracellular protein matrix synthesis through induction of transforming growth factor-β expression in rat glomerular mesangial cells. J. Clin. Invest., 93, 2431-2437.
62. Kopp, J.B., Factor, V.M., Mozes, M., Nagy, P., Sanderson, N., Bottinger, E.P., Klotman, P.E. and Thorgeirsson, S.S. (1996) Transgenic mice with increased plasma levels of TGF-β1 develop progressive renal disease. Lab. Invest., 74, 991-1003.
63. Heathcott, R.W., Morison, I.M., Gubler, M.C., Corbett, R. and Reeve, A.E. (2002) A review of the phenotypic variation due to the Denys-Drash syndrome-associated germline WT1 mutation R362X. Hum. Mutat., 19, 462-466.
64. Chak, W.L., To, K.F., Cheng, Y.L., Tsui, K.M., Lo, K.W., Tong, H.M., Lai, F.M-C., Wong, F.K.M., Choi, K.S., Chau, K.F. et al. (2002) Gonadal mosaicism of Frasier syndrome in 3 chinese siblings with donor splice site mutations of Wilms' tumour gene. Nephron, 91, 526-529.
65. Denys, P., Malvaux, P., Van Den Berghe, H., Tanghe, W. and Proesmans, W. (1967). Association of an anatomo-pathological syndrome of male pseudo-hermaphroditism, Wilms' tumour, parenchymatous nephropathy and XX/ XY mosaicism. Arch. Fr. Pediat., 24, 729-739.
66. Swiatecka-Urban, A., Mokrzycki, M.H., Kaskel, F., Da Silva, F. and Denamur, E. (2001) Novel WT1 mutation (C388Y) in a female child with Denys-Drash syndrome. Pediatr. Nephrol., 16, 627-630.
67. McCullagh, P. and Nelder, J.A. (1993) Generalised Linear Models. Chapman and Hall, London.
68. Sokal, R.R. and Rohlf, F.J. (1995) Biometry, 3rd edn. W.H. Freeman, New York.
69. Clark, A.F., Sharp, M.F., Morley, S.D., Fleming, S., Peters, J. and Mullins, J.J. (1997) Renin-1 is essential for normal renin juxtaglomerular cell granulation and macula densa morphology. J. Biol. Chem., 272, 18185-18190.